中国肿瘤临床
中國腫瘤臨床
중국종류림상
CHINESE JOURNAL OF CLINICAL ONCOLOGY
2014年
12期
762-765
,共4页
李超英%陈文文%王楚盈%杨琳琳%迟源%张大方
李超英%陳文文%王楚盈%楊琳琳%遲源%張大方
리초영%진문문%왕초영%양림림%지원%장대방
鸦胆子油口服乳液%二乙基亚硝胺%原发性肝癌%抑制作用
鴉膽子油口服乳液%二乙基亞硝胺%原髮性肝癌%抑製作用
아담자유구복유액%이을기아초알%원발성간암%억제작용
s:oral javanica oil emulsion%diethylnitrosamine%primary liver cancer%suppression mechanism
目的:探讨鸦胆子油口服乳液对二乙基亚硝胺(DEN)诱导的大鼠原发性肝癌的抑制作用。方法:将大鼠随机分为正常对照组、模型对照组、鸦胆子油口服乳液组。采用自由饮水和灌胃给DEN的方法诱发大鼠肝癌模型,诱发肝癌第5周开始灌胃鸦胆子油口服液,5次/周,14周后处死大鼠,腹主动脉取血,全自动生化分析仪检测血清中ALT、AST、ALP、γ-GT和AFP的含量,观察大鼠肝系数、脾系数、胸腺系数、肝脏表面的癌结节数的变化,并进行影像学检查。结果:与正常对照组比较,模型对照组肝、脾指数和癌结节数明显增加,胸腺指数明显降低(P<0.01),血清中ALT、AFP、AST、ALP、γ-GT的水平显著高于正常对照组(P<0.01);与模型组比较,鸦胆子油口服乳液显著降低肝癌大鼠肝指数、脾指数、癌结节数,升高胸腺指数(P<0.01),血清中ALT、AFP、AST、ALP、γ-GT的水平得到明显改善(P<0.01或P<0.05)。结论:鸦胆子油口服乳液对原发性肝癌具有显著抑制作用,并且作用机制为多方面。
目的:探討鴉膽子油口服乳液對二乙基亞硝胺(DEN)誘導的大鼠原髮性肝癌的抑製作用。方法:將大鼠隨機分為正常對照組、模型對照組、鴉膽子油口服乳液組。採用自由飲水和灌胃給DEN的方法誘髮大鼠肝癌模型,誘髮肝癌第5週開始灌胃鴉膽子油口服液,5次/週,14週後處死大鼠,腹主動脈取血,全自動生化分析儀檢測血清中ALT、AST、ALP、γ-GT和AFP的含量,觀察大鼠肝繫數、脾繫數、胸腺繫數、肝髒錶麵的癌結節數的變化,併進行影像學檢查。結果:與正常對照組比較,模型對照組肝、脾指數和癌結節數明顯增加,胸腺指數明顯降低(P<0.01),血清中ALT、AFP、AST、ALP、γ-GT的水平顯著高于正常對照組(P<0.01);與模型組比較,鴉膽子油口服乳液顯著降低肝癌大鼠肝指數、脾指數、癌結節數,升高胸腺指數(P<0.01),血清中ALT、AFP、AST、ALP、γ-GT的水平得到明顯改善(P<0.01或P<0.05)。結論:鴉膽子油口服乳液對原髮性肝癌具有顯著抑製作用,併且作用機製為多方麵。
목적:탐토아담자유구복유액대이을기아초알(DEN)유도적대서원발성간암적억제작용。방법:장대서수궤분위정상대조조、모형대조조、아담자유구복유액조。채용자유음수화관위급DEN적방법유발대서간암모형,유발간암제5주개시관위아담자유구복액,5차/주,14주후처사대서,복주동맥취혈,전자동생화분석의검측혈청중ALT、AST、ALP、γ-GT화AFP적함량,관찰대서간계수、비계수、흉선계수、간장표면적암결절수적변화,병진행영상학검사。결과:여정상대조조비교,모형대조조간、비지수화암결절수명현증가,흉선지수명현강저(P<0.01),혈청중ALT、AFP、AST、ALP、γ-GT적수평현저고우정상대조조(P<0.01);여모형조비교,아담자유구복유액현저강저간암대서간지수、비지수、암결절수,승고흉선지수(P<0.01),혈청중ALT、AFP、AST、ALP、γ-GT적수평득도명현개선(P<0.01혹P<0.05)。결론:아담자유구복유액대원발성간암구유현저억제작용,병차작용궤제위다방면。
Objective: This study aimed to investigate the inhibitory effects of Brucea javanica oil oral emulsion (BJOOE) on primary liver cancer induced by diethylnitrosamine (DEN). Methods:Rats were randomly divided into the control group, model group, and BJOOE group. Rats were given free access to water. DEN was administered intragastrically to induce liver cancer in rats. Five weeks later, rats were intragastrically administered with BJOOE for five times per week. The rats were killed after 14 weeks. Abdominal aortic blood samples were collected. The contents of ALT, AST, ALP, γ-GT, and AFP of serum were detected by an automatic biochemical analyzer. The liver index, spleen index, thymus index, and changes in liver cancer nodules of the surface were observed in rats. Changes in the number of liver cancer nodules of the surface were detected by imaging. Results:Compared with the control group, the liver index, spleen index, and number of nodules of the model group significantly increased, whereas the thymus index significantly decreased (P<0.01). The levels of ALT, AFP, AST, ALP, andγ-GT of serum in the model group were significantly higher than those in the control group (P<0.01). Compared with the model group, BJOOE significantly reduced the liver index, spleen index, and number of cancer nodules, but increased the thymus index in the liver of rats with cancer (P<0.01). The levels of ALT, AFP, AST, ALP, andγ-GT of serum in rats with hepatic carcinoma significantly improved (P<0.01 or P<0.05). Conclusion:BJOOE could inhibit primary liver cancer, and the underlying mechanisms are complex.